The development of pathogenic mechanisms, specific antiviral treatments and preventive vaccines for hepatitis C virus (HCV) infection has been limited due to lack of cell culture models that can naturally imitate the entire HCV life cycle. Here, we established an HCV cell culture model based on human fetal liver stem cells (hFLSCs) that supports the entire blood-borne hepatitis C virus (bbHCV) life cycle. More than 90% of cells remained infected by various genotypes. bbHCV was efficiently propagated, and progeny virus were infectious to hFLSCs. The virus could be passed efficiently between cells. The viral infectivity was partially blocked by specific antibodies or small interfering RNA against HCV entry factors, whereas HCV replication was inhibited by antiviral drugs. We observed viral particles of approximately 55 nm in diameter in both cell culture media and infected cells after bbHCV infection. Conclusion: Our data show that the entire bbHCV life cycle could be naturally imitated in hFLSCs. This model is expected to provide a powerful tool for exploring the process and the mechanism of bbHCV infection at the cellular level and for evaluating the treatment and preventive strategies of bbHCV infection.
The development of pathogenic mechanisms, specific antiviral treatments and preventive vaccines for hepatitis C virus (HCV) infection has been limited due to lack of cell culture models that can naturally imitate the entire HCV life cycle. Here, we established an HCV cell culture model based on human fetal liver stem cells (hFLSCs) that supports the entire blood-borne hepatitis C virus (bbHCV) life cycle. More than 90% of cells remained infected by various genotypes. bbHCV was efficiently propagated, and progeny virus were infectious to hFLSCs. The virus could be passed efficiently between cells. The viral infectivity was partially blocked by specific antibodies or small interfering RNA against HCV entry factors, whereas HCV replication was inhibited by antiviral drugs. We observed viral particles of approximately 55 nm in diameter in both cell culture media and infected cells after bbHCV infection. Conclusion: Our data show that the entire bbHCV life cycle could be naturally imitated in hFLSCs. This model is expected to provide a powerful tool for exploring the process and the mechanism of bbHCV infection at the cellular level and for evaluating the treatment and preventive strategies of bbHCV infection. (HEPA-TOLOGY 2017;66:1045-1057).
H epatitis C virus (HCV) is a positive-strand
RNA virus that was identified by molecular cloning in 1989 and classified into seven genotypes within its own genus. Over 160 million individuals have been infected with HCV worldwide, and approximately 80% of cases lead to chronic liver disease. At present, no vaccines are available to prevent HCV infection. Current treatments are effective for most patients with chronic infection, but drug resistance and the high cost of direct-acting antivirals remain important problems. (1, 2) The inability to efficiently cultivate HCV in vitro has presented major obstacles in understanding its pathogenesis and developing effective therapeutics. This is because HCV has high host specificity and infection is limited mainly to primates (e.g., humans and chimpanzees). (3) HCV propagation in vivo occurs mainly in highly differentiated and nondividing hepatocytes; thus, primary cultures of human adult hepatocytes (PHHs) are among the best candidates in establishing a cell culture model. (4, 5) However, despite numerous attempts to infect PHHs using blood-borne hepatitis C virus (bbHCV), low efficiencies of infection (low viral titers between 10 4 and 10 6 copies/lg of total RNA), decreased virus production over time, short infection duration (below 15 d), and the fact that mature functioning hepatocytes cannot be readily expanded in culture are significant limitations to the demonstration of the entire bbHCV life cycle. (4) (5) (6) (7) (8) In 2005, the construction of a cell culture model based on transfection of full JFH-1 genome RNA into Huh-7 cells was a breakthrough in HCV research. (9) (10) (11) Unfortunately, metabolic differences exist between hepatoma cell lines and quiescent primary hepatocytes. It has become apparent that these cell lines may not fully recapitulate all aspects of HCV replication in the liver, or host responses that play an important role in determination of viral persistence or clearance. (12) In the last few years, differentiated human hepatocyte-like cells derived from human embryonic or induced pluripotent stem cells have been proposed as alternative models. (13) (14) (15) These cells offer the opportunity to explore the host genetic factors that influence the viral pathogenesis and response to treatments. Nevertheless, even the most advanced protocols result only in heterogeneous cell populations that are not fully differentiated. In addition, the low efficiency of infectivity and replication of bbHCV seriously impacts its application. Recently, Yang et al. (16) reported the establishment of a novel hepatoma cell line, HLCZ01, which supported the infection of bbHCV. However, the typical HCV particles in culture media and infected cells were not observed by electron microscopy (EM). Therefore, until now, there has been no ideal cell culture model that could thoroughly exhibit the entire HCV life cycle, including viral adsorption and invasion, RNA replication, protein synthesis, viral assembly, and secretion of mature virions.
Based on strong tropism for liver parenchymal cells of HCV, we propose that human fetal liver stem cells (hFLSCs) may be used to develop an infection model for bbHCV. hFLSCs not only expressed HCVspecific receptor-CD81, but also expressed both hepatic (AFP and CK18) and biliary (CK19) specific surface markers, which may create appropriate hepatocyte-like micro-environments for HCV propagation. (17) Other advantages include its potential ability to serially subpassage and differentiate into hepatocytes. These characteristics satisfy the strong tropism of HCV for liver cells and the requirements for reproduction and preservation. In this study, we report an infection system based on hFLSCs that could thoroughly exhibit the entire bbHCV life cycle and could pass the virus efficiently between cells. This system would provide a useful tool for studying HCV-host cell interactions, antiviral drug screening, and preventive vaccine development at the cellular level.
Materials and Methods

ETHICS
This study was performed in accordance with the Declaration of Helsinki (2000) 
CELL ISOLATION AND CULTURE
Human fetal liver tissues were obtained from legally aborted fetuses at 12-20 weeks gestation in accordance with our institute's ethical guidelines. All the donors had been serologically screened for syphilis, toxoplasmosis, rubella, hepatitis B and C, human immunodeficiency virus 1, cytomegalovirus, parvovirus, and herpes simplex types 1 and 2. In the last 5 years, we acquired five fetal livers used to separate hFLSCs, and all those cells could be efficiently infected by bbHCV. Cells
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were isolated and cultured according to a previously described protocol. (17) Detailed information regarding hFLSCs is provided in the Supporting Information.
HCV SERUM SAMPLES
HCV-positive serum samples were obtained from patients with chronic HCV infection treated at the Peking Union Medical College Hospital. Informed consent was obtained from all patients, and patients did not receive any antiviral therapy before the study. All donors had been serologically screened for syphilis, toxoplasmosis, rubella, hepatitis B, human immunodeficiency virus 1, cytomegalovirus, parvovirus, and herpes simplex types 1 and 2. Donor information is provided in Supporting Table S1 .
INFECTION OF hFLSCs WITH bbHCV AND THE PROGENY VIRUS
Sera were filtered through 0.22-lm polarized filters before infection. hFLSCs, Huh7 cells, and Huh7.5.1 cells were grown to a 1 3 10 5 density in six-well plates, and 2.4 3 10 6 genome copies (GC)/mL of bbHCV or 2.3 3 10 6 GC/mL of progeny virus with 1 mL of serum-free culture media were added to each well. After incubating for 8 hours, cells were rinsed with Dulbecco's modified Eagle's medium (DMEM)/F 12 . The final wash was collected and detected by way of reverse-transcription quantitative polymerase chain reaction (RT-qPCR) to confirm the absence of HCV RNA. Then, we added 1 mL of DMEM/F 12 (hFLSCs) or DMEM (Huh7 and Huh7.5.1 cells) with 10% fetal bovine serum for culturing. Huh7.5.1 cells were also infected by HCV in cell culture (HCVcc) (pFL-J6/JFH was kindly provided by Dong Yangchao, Fourth Military Medical University, Xi'an, China) as described previously. (18) HCVcc was generated as described previously. (19) hFLSCs and Huh7.5.1 cells were inoculated overnight with HCVcc at a multiplicity of infection of 0.1, and the inoculum was removed. The cells were maintained and harvested at the indicated times. The supernatant was collected every other day during the culture period and was stored at 2808C. Cells were passaged every 2 days. Half of the population was used to continue cultivation and half was frozen (DMEM/F12, fetal bovine serum and dimethyl sulfoxide at a 7:2:1 ratio [v/v], respectively) in cryo-freezing containers (Nalge Nunc International, Penfield, NY).
STATISTICAL ANALYSIS
All experiments were conducted in at least three separate experiments in duplicate. Data are expressed as the mean 6 standard deviation and were analyzed with SPSS for Windows (version 17.0; SPSS Inc., Chicago, IL). P < 0.05 was considered statistically significant.
ADDITIONAL METHODS
Detailed methodology is described in the Supporting Information.
Results
HIGH VIRUS PRODUCTION FROM hFLSCs INFECTED WITH bbHCV
To determine whether virus could be produced by infecting hFLSCs, cells were infected with 2.4 3 10 6 GC of bbHCV (genotype 2a, sera ID: 146) and Huh7.5.1 cells infected by HCVcc were used as a positive control. It was found that the yield of HCV RNA increased over time, and reached peak at 24 hours postinfection in culture media. After that, HCV RNA levels revealed a fluctuating pattern, which remained between 10 5 and 10 7 GC/mL of culture media during the entire 60-day infection period (Fig. 1A and Supporting Fig. S1A ,B). When cells were incubated with HCV genotypes 1a, 1b, 2a, and 3a, similar HCV RNA yields (10 6 -10 7 GC/mL of culture media) were obtained (Supporting Fig. S1C -E). However, sofosbuvir, an effective HCV polymerase inhibitor, (20) significantly inhibited the yield of HCV RNA (Fig. 1A) . These results suggest that hFLSCs were susceptible to HCV genotypes 1a, 1b, 2a, and 3a. Exposure of Huh7 and Huh7.5.1 cells under identical conditions resulted in little or no signal corresponding to viral RNA (Supporting Fig. S1F ), on the contrary, Huh7.5.1 cells infected by HCVcc could obtain a high virus response (Fig. 1A) .
HCV proteins were detected in cell culture media by way of western blot analysis. It was demonstrated that HCV structural and nonstructural proteins ( (21) which is a HCV NS3/4A proteinase inhibitor (Fig. 1C) . Calnexin, an endoplasmic reticulum (ER)-associated chaperone protein colocalized with HCV envelope glycoproteins in infected cells, (22) was detected in cell supernatant, which probably associated with the large amount of NS3 that might come from cells floating in supernatant or debris from lysed cells detected in the supernatant (Fig. 1B) .
More importantly, we also observed spherical particles with a mean diameter of approximately 55 nm (Fig. 1D ) in culture media by EM, which is similar to those that have been described previously. (9, 23) The inner ring of these virus particles had a slight angular morphology and a diameter of 30-35 nm, which was consistent with that of a nucleocapsid. HCV particles were also visualized by immune electron microscopy (IEM) using an E1-specific antibody and revealed gold-labeled spherical structures with an electrondense inner core (Fig. 1E ). These findings indicate that hFLSCs were susceptible to bbHCV infection and supported highly efficient HCV RNA replications, protein synthesis, and production of intact virus particles. 
bbHCV ADSORPTION AND INVASION IN hFLSCs
To explore the interaction between bbHCV and hFLSCs, cells were incubated with 2.4 3 10 6 GC of bbHCV, and three-dimensional structured illumination microscopy (3D-SIM) was used to determine whether HCV was able to make contact with hFLSCs. Results revealed a wide distribution of HCV-specific receptor-CD81 and virus E2 on the surface of infected hFLSCs ( Fig. 2A) . More importantly, we observed the integration of CD81 and E2 in infected cells (Supporting Fig. S2A ). 3D-SIM was used to reconstruct immunofluorescent images of one infected cell, which clearly revealed the binding state of CD81 and E2 (Supporting Fig. S2B ). We also found that HCV RNA in infected hFLSCs was detectable after 4 hours and reached a plateau at 14 hours postinfection (Supporting Fig. S3A ). However, sofosbuvir only inhibited the production of the virus after exposure to bbHCV (Supporting Fig. S3A,B) .
We next assessed whether bbHCV infection was inhibited by antibody mediated against cell surface receptors or virus-specific antigens. Compared with cells treated with irrelevant immunoglobulin G (IgG) control antibodies, bbHCV and HCVcc infection, which were measured by intracellular HCV RNA levels, were significantly reduced in cells treated with an antibody specific for CD81 or E2 (Fig. 2B and Supporting Fig. S3C,D) .
In addition, we investigated whether the susceptibility of hFLSCs to bbHCV infection correlated with previously identified HCV host receptors including CD81, scavenger receptor class B type I (SR-BI), claudin-1 (CLDN1), occludin (OCLN), NiemannPick C1-like 1 (NPC1L1), epidermal growth factor receptor (EGFR), and EphA2. We found that the expression of these receptors significantly increased after infection (Fig. 2C,D) . Compared with cells transfected with an irrelevant control small interfering RNA (siRNA), CD81, SR-BI, NPC1L1, or EGFR, silenced cells were apparently less susceptible to bbHCV infection ( Fig. 2E and Supporting Fig. S4) .
We also observed gold-labeled structures in the cytoplasm of bbHCV-infected hFLSCs in the early period of infection (8 hours) under IEM ( Fig. 2F and Supporting Fig. S5 ).
Taken together, these results suggest that this model could simulate the early events of bbHCV infection, including the binding of receptors and ligands on infected cells and the penetration of virus in cells.
bbHCV RNA REPLICATION AND PROTEIN SYNTHESIS IN hFLSCs
To demonstrate bbHCV RNA replication and protein synthesis in hFLSCs, HCV RNA and proteins in infected hFLSCs were measured for 60 days. HCV RNA levels remained between 10 5 and 10 7 GC per 10 5 cells during the entire period (Fig. 3A) . More importantly, intermittently quantitative detection of both positive-and negative-strand HCV RNA in cells demonstrated that genome replication occurred ( Fig.  3B and Supporting Fig. S6 ). Sequence analysis of a target fragment (length: 496 bp, KP721476) revealed a 100% match with the original HCV genome sequence used to initiate infection. Meanwhile, HCV RNA replication was inhibited by sofosbuvir and peginterferon a-2a in a dose-dependent manner (Supporting Fig.  S3B and S7A) .
HCV protein expressions were analyzed in infected cells by way of western blot analysis. It was demonstrated that the infected hFLSCs expressed HCV structural and nonstructural proteins efficiently during the entire 60-day period (Fig. 3C) , indicating that hFLSCs supported HCV protein synthesis. The number of HCV protein (1) cells increased with time and reached a plateau at 72 hours after infection. During this period, more than 90% of hFLSCs were positive as detected by immunofluorescence assay and flow cytometry ( Fig. 3D and Supporting Fig. S7B,C) . Protein synthesis was inhibited by danoprevir in a dosedependent manner (Fig. 3E and Supporting Fig.  S7D ).
The infectivity of bbHCV was transferred to na€ ıve hFLSCs (Supporting Fig. S8A ). Sofosbuvir or danoprevir inhibited the passage of the virus from infected hFLSCs to na€ ıve hFLSCs (Supporting Fig. S8B) .
To better understand the interaction between bbHCV and host cells, innate immune response was tested in infected cells. Interferon-stimulated genes were induced in virus-infected cells (Supporting Fig.  S9A ), indicating that hFLSCs mounted an innate immune response to bbHCV infection. Our results also show that the expressions of phosphorylated STAT1 increased slightly in hFLSCs infected by bbHCV, but the interferon-a production was barely detected (Supporting Fig. S9B,C) . It was also reported that microRNAs regulate a wide range of biological processes and participate in innate and adaptive immune responses, and miR-21 and miR-122 are highly expressed in HCV-positive liver biopsy specimens. (24) We determined the levels of miR-21 and 
FIG. 2. bbHCV adsorption and invasion in hFLSCs. (A) hFLSCs immunostained with antibodies against CD81 and HCV E2
were analyzed using 3D-SIM, and two specific antibodies colocalized on the cell surface. Scale bar, 5 lm. (B) Blockage of HCV infection in hFLSCs by anti-hCD81 (left) and anti-HCV E2 (right) antibodies. hFLSCs were exposed to increasing concentrations of antihCD81 antibody before inoculation with bbHCV, or viruses were incubated with various concentrations of anti-HCV E2 antibody before incubation with hFLSCs, and irrelevant mouse monomeric IgG or rabbit monomeric IgG were run in parallel to serve as isotype controls. Intracellular HCV RNA was measured by way of RT-qPCR, and the supernatants were harvested and titered by ffu assays on na€ ıve hFLSCs. miR-122 in infected hFLSCs. The results revealed that miR-21 and miR-122 levels were increased in hFLSCs after 4 hours of infection and reached a peak at 24 hours postinfection (Supporting Fig. S10A ). To determine whether miR-21 and miR-122 facilitated bbHCV infection, hFLSCs were transfected with miR-21 and miR-122 and were infected by bbHCV (Supporting Fig. S10B,C) . As expected, miR-21 and miR-122 mimics contributed to HCV RNA replication and protein synthesis, and the opposite occurred in miR-21 and miR-122 inhibitors (Supporting Fig.  S10D-F) .
PROGENY VIRUS ASSEMBLY AND SECRETION IN hFLSCs
The production of mature progeny virus from infected cells is a very important marker of a successful simulation of the whole bbHCV life cycle. Typical HCV particles with a diameter of approximately 55 nm in the cytoplasm of infected hFLSCs were observed (Fig. 4A,B and Supporting Fig. S11A ). (25, 26) Immunogold-labeled ultrathin sections showed that labeled spherical structures existed in the cytoplasm of HCV-infected hFLSCs (Fig. 4C-E and Supporting Fig. S11B-D) and were similar to the descriptions of other viruses of the Flaviviridae family. (27) However, the immunogold-labeled spherical structures were not observed in hFLSCS infected by HCVcc (Supporting Fig. S12A,B) . Highly organized vesicular structures of up to 600 nm in diameter surrounded by immunogold were found delimited by a single membrane (Fig. 4E) . These structures contained spherical and electrondense structures that were approximately 50 nm in diameter. Some sections revealed the presence of immunogold-labeled spherical particles in the ER (Fig. 4F) . Quantitative analysis of immunogoldlabeled structure revealed that the distribution of gold particles in bbHCV-infected group differs between the noninfected group (Supporting Table S4 ; total chisquare value, 19.46; P < 0.01). In addition, we found colocalization of two types of fluorescence signals of HCV proteins (E1 and E2) on infected hFLSCs by way of 3D-SIM, which may further demonstrate complete virus particles in infected hFLSCs (Supporting Fig. S13 ). These results revealed that the progeny virus could be successfully assembled in infected hFLSCs.
To elucidate the replication and release of HCV, we developed a dynamic model that fits viral load data in an attempt to examine various features of the viral life cycle. In this model, rate of cell growth as well as virus generation and secretion were all constants (w c , w v and < w s ). The growth curve of hFLSCs fit our mathematical model (R 2 5 0.975) very well (Fig. 5A) . We calculated a cell growth rate of w c 5 0.467 h 2 from the growth curve. The growth rate determined in this study was similar to a previous report on hFLSCs. (17) For virus generation and secretion, the mathematical model fitted all curves well based on virus titers (R 2 5 0.991 and 0.996; Fig. 5B,C ). Based on model fitting, we calculated the growth and secretion rates of w v 5 0.548 h 2 and w s 50.080 h 2 , respectively. The results revealed that virus growth rate was equal to the sum of the virus secretion rate and cell growth rate, suggesting that virus growth may be synchronous to cell division. Virus production could vary with cell growth in a limited resource system.
In addition, apolipoprotein J (ApoJ) and diacylglycerol acyltransferase-1 (DGAT1) have been identified to be critical for HCV release in previous studies. (28, 29) hFLSCs infected with bbHCV revealed elevated intracellular mature ApoJ and DGAT1 levels (Fig. 5D ). hFLSCs were transfected with siRNAs targeting ApoJ and DGAT1. Viral RNA released into the supernatant was reduced by approximately 75%, whereas intracellular viral RNA concentrations remained accumulated (Fig. 5E,F) . These results indicate that infected hFLSCs produced enough mature ApoJ and DGAT1 to support virion release.
THE PROGENY VIRUS PROPERTY
To understand the infectivity of the progeny virus, we attempted to infect hFLSCs with 2.3 3 10 6 GC/ mL of progeny virus and found that NS5A-positive cells could be observed readily (Supporting Fig.  S14A ). Extracellular and intracellular viral RNA increased with culture time to 10 5 -10 6 GC/mL of culture media or 10 5 cells, which remained stable for at least 30 days (Fig. 6A) . Focus-forming units (ffu) per mL were calculated to show the infectivity of the progeny virus. The results revealed that this infectivity was maintained between 4.5 and 5.5 3 10 4 ffu/mL after infection (Fig. 6B) . Viral replication and infectivity were higher in hFLSCs than in Huh7.5.1 cells (Fig.  6C,D) .
Next, we amplified the complete genome sequences of progeny virus with 12 primer sets to determine whether progeny virus contained an entire HCV genome. The results revealed that the full-length gene of the progeny virus was 9.6 Kb (KP721475; Supporting Fig. S14B ). Phylogenetic analysis of full-length sequences demonstrated that the progeny virus genotype shared 100% homology with the parental bbHCV (genotype 2a; Fig. 6E ).
To further characterize the biophysical properties of the progeny virus, culture media collected from mockinfected and infected hFLSCs were subjected to sucrose gradient centrifugation. Gradient fractions were collected after centrifugation and analyzed for the (F) Biophysical properties of the progeny virus. Culture media from bbHCV mock-infected or infected hFLSCs were fractionated using a 10%-60% sucrose density gradient. HCV RNA titers and infectivity in each fraction were determined by way of RT-qPCR and ffu assay on na€ ıve hFLSCs, and the fraction densities are expressed as g/mL. ND, not detectable.
presence and infectivity of HCV RNA. Maximal infectivity titers (4.7 3 10 6 ffu/mL) were present in fraction 5 (approximately 1.15 g/mL), which coincided with the peak value of HCV RNA (4.25 3 10 7 GC/ mL) and were consistent with the previous report of Wakita et al. (9) (Fig. 6F) . In purified viral suspensions from fraction 5, we observed spherical particles with a mean diameter of approximately 55 nm by way of IEM using an E1-specific antibody (Fig. 1E) .
Discussion
A successfully established cell culture model of HCV infection should meet the following criteria: (1) susceptible to HCV with high efficiency; (2) HCV could propagate in cells and HCV markers (specific proteins and RNA) could be detected in cells; (3) mature progeny virus could be secreted into culture media; (4) and remain infectious to cells again; and (5) cells should be easy to obtain and could be serially passaged. However, there is no HCV culture model in vitro that currently meets these demands.
In the current study, the hFLSCs culture system may meet the above requirements and naturally imitate the entire bbHCV life cycle, including viral adsorption and invasion, RNA replication, protein synthesis, viral assembly, and secretion of infectious virions (Supporting Fig. S15 ). We directly showed the combination of HCV E2 protein and CD81 receptor by 3D-SIM. In addition, hFLSCs could express all previously identified HCV receptors, including SR-BI, CLDN1, OCLN, NPC1L1, EGFR, and EphA2, in addition to CD81. (30, 31) However, the existing cells for culturing bbHCV only expressed one or several of these receptors, (15, 32) which might partially explain the susceptibility of hFLSCs to bbHCV infection. Antibodies directed against HCV E2 and CD81 or siRNA specific to the identified receptors that reduced the infectivity of bbHCV strongly indicated that bbHCV infection of hFLSCs followed the natural entry pathway, and that the early process of viral adsorption and entry of bbHCV can be studied in this system. Specific HCV RNA and proteins were shown to be replicated and synthesized in hFLSCs. Negativestrand HCV RNA detection demonstrated that viral genome replication occurred in hFLSCs. (33) Meanwhile, high HCV core and E1, E2, and NS3 protein expression in infected hFLSCs indicated that virus proteins were produced in hFLSCs. The current data show that HCV could spread by cell-to-cell transmission, and the percentage of bbHCV-infected cells could rapidly increase to 90%. These results accounted for the high yield of infectious HCV particles observed with this system. In contrast to our culture system, other studies have reported that the proportion of cells that expressing viral proteins was only 10%-20% after bbHCV infection. (3, 34) On the other hand, HCV RNA replication was partially inhibited by peginterferon-a2a, and the polymerase inhibitor sofosbuvir, and protein synthesis was inhibited by danoprevir significantly. Taken together, these findings indicate that this in vitro culture model may be used to evaluate specific antiviral drugs for HCV. It is difficult to develop cell culture systems for bbHCV, especially for various genotypes, due to potential inter-genotypic incompatibility. Our method could be readily applied to different kinds of clinical isolates (1a, 1b, 2a, and 3a); since it might not rely on sequence homology, only on functional selection. (3) We observed and identified mature viral particles of approximately 55 nm in diameter in culture media and bbHCV infected cells by EM and IEM. The data indicate that bbHCV not only replicates in hFLSCs, but also assembles mature viral particles and secretes them into culture media. HCV propagation induced the production of numerous 600 nm wide vesicular structures, which were similar to those observed by biochemical and ultrastructural analyses of replication complexes in various Flaviviridae, including West Nile virus, Japanese encephalitis virus, and dengue virus. (27, 35, 36) It has been suggested that HCV-induced membrane alterations are particularly heterogeneous with irregular assemblies of membranous vesicles. (23, 37, 38) Moreover, concealment of its replicated RNA in vesicular structures may constitute an additional mechanism of escape from innate immune responses. (39, 40) In this current study, the large number of vesicular structures in hFLSCs harboring bbHCV may be related to high levels of HCV replication. Evidence that interferon-stimulated genes and microRNA (miR-21 and miR122) were induced in bbHCVinfected hFLSCs suggests that this cell culture system may be used for the analysis of host-virus interactions.
Secreted HCV virions were infectious to na€ ıve hFLSCs. More importantly, considering the dynamics of HCV-infected hFLSCs, doubling time for HCV was approximately 2 hours, which is similar to previous reports in infected humans and chimpanzees. (41, 42) The times for viral RNA to enter and reach its peak in hFLSCs (14 hours) and subsequent progeny virus secretion into culture media (24 hours) were shorter than those described in existing models. (6, 43) These results partially explain why this system produces a high yield of infectious HCV particles.
Finally, to develop a perfect bbHCV cell culture model, cells should be accessible and propagative. There are some difficulties in hFLSC isolation and culture. However, several previous reports were successful. (44) (45) (46) We have recently improved the isolation and culture condition of hFLSCs, which resulted in high proliferative capacity, allowing subpassaging for more than 20 passages without differentiation. (17) Therefore, propagation of hFLSCs used for this HCV model did not create bottlenecks in the availability of cells for experiments.
